-The Hindu The New Drugs, Medical Devices and Cosmetics Bill is antiquated and needs to be revised The Union Health Ministry recently published a new draft Bill to replace the antiquated Drugs and Cosmetics Act, 1940. While we salute the Ministry for recognising the need for a new legislation, there is much to disagree with the new Bill. To begin with, although the Ministry has described it as being consistent with the...
More »SEARCH RESULT
Total Matching Records found : 63
It’s Been Two Years Since the Poster Child of UP’s Farming Success Story Quit Active Farming -Ajoy Ashirwad Mahaprashasta
-TheWire.in Subhrant Shukla once made news for leaving a corporate job for agriculture and introducing progressive practices to farming. Now he is besieged by losses and is no longer wearing 'saffron-tinted glasses'. Lakhimpur Kheri: Subhrant Shukla’s Facebook cover image, announces, “Haan, main kisaan hoon (‘Yes, I am a farmer’)”. Except he quit professional farming two years ago after running into severe losses over the last few years. “I was a proud farmer but...
More »Making India Inc. accountable -Vidya Venkat
-The Hindu It is not the responsibility of the government alone to act in order to curb corruption; corporate firms need to be proactive as well in checking fraudulent financial practices The winter session of Parliament witnessed a noisy debate on the black money controversy. Governments of all hues have disappointed the Indian janata on the issue of black money and the failure is often associated with a perceived nexus between politicians...
More »Why do Indian health authorities keep quiet on pharma firms' failings? -Nivedita Mookerji
-Business Standard Domestic regulators need to be stricter about quality violations to protect both Indian pharma exports as well as the country's image Even as major Indian drug companies continue to make news for impurities in the medicines they make and faulty - or if the USFDA is to be believed, falsified - data that many generate after testing of samples show quality problem, it seems strange that domestic authorities are silent...
More »Billing for wallet shock -Digbijay Mishra
-Business Standard Indian and other generic drug firms face prospect of US legislature debating compensation for undue price rises Indian generic drug makers might, if a proposed US law comes about, need to pay a rebate to the federal Medicaid programme there when prices of their medications outpace inflation. A Bill is to be introduced in the US Senate by a member, aimed to cushion the impact on taxpayers in this manner...
More »
